Issued Patents All Time
Showing 25 most recent of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12091400 | Piperidine derivatives as METTL3 inhibitors | Guillaume Dutheuil, Catherine SORLET, Killian OUKOLOFF, Francois Lenoir, Julien KORAC | 2024-09-17 |
| 11731974 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Guillaume Dutheuil | 2023-08-22 |
| 11478472 | NK-3 receptor antagonists for therapeutic treatment of leptin-related disease | Hamid R. Hoveyda | 2022-10-25 |
| 10941151 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Guillaume Dutheuil, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2021-03-09 |
| 10836768 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Guillaume Dutheuil | 2020-11-17 |
| 10683295 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Guillaume Dutheuil, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2020-06-16 |
| 10624890 | NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat | Hamid R. Hoveyda | 2020-04-21 |
| 10544150 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Hamid R. Hoveyda, Marie-Odile Roy, Guillaume Dutheuil | 2020-01-28 |
| 10258602 | Macrocyclic ghrelin receptor modulators and methods of using the same | Hamid R. Hoveyda, Kamel Benakli, Eric Marsault, Mark L. Peterson | 2019-04-16 |
| 10214533 | N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Guillaume Dutheuil | 2019-02-26 |
| 10183948 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Guillaume Dutheuil | 2019-01-22 |
| 10065961 | Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Guillaume Dutheuil, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2018-09-04 |
| 10065960 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Hamid R. Hoveyda, Marie-Odile Roy, Guillaume Dutheuil | 2018-09-04 |
| 10030025 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Guillaume Dutheuil | 2018-07-24 |
| 9987274 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Guillaume Dutheuil | 2018-06-05 |
| 9969738 | N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Guillaume Dutheuil | 2018-05-15 |
| 9969745 | N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Guillaume Dutheuil | 2018-05-15 |
| 9949949 | Macrocyclic ghrelin receptor modulators and methods of using the same | Hamid R. Hoveyda, Kamel Benakli, Eric Marsault, Mark L. Peterson | 2018-04-24 |
| 9926325 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Hamid R. Hoveyda, Marie-Odile Roy, Guillaume Dutheuil | 2018-03-27 |
| 9840508 | N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Guillaume Dutheuil | 2017-12-12 |
| 9770435 | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq, Jerome Bernard | 2017-09-26 |
| 9475814 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Guillaume Dutheuil, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2016-10-25 |
| 9422299 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Guillaume Dutheuil | 2016-08-23 |
| 9371297 | Macrocyclic ghrelin receptor modulators and methods of using the same | Hamid R. Hoveyda, Kamel Benakli, Sophie Beauchemin, Martin Brassard, Eric Marsault +3 more | 2016-06-21 |
| 9133235 | Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders | Eric Marsault, Kamel Benakli, Carl St-Louis, Alain Rouillard, Helmut Thomas | 2015-09-15 |